Cel
Counteracting high attrition rates in oncology drug development and providing optimal therapeutic management of cancer patients require preclinical models that properly recapitulate the complexity and diversity of human tumours. Patient-derived tumour xenografts (PDXs), established by transplanting tumour fragments into immunodeficient mice, are being widely embraced by the scientific community as preclinical tools for target and biomarker discovery. The overall goal of EDIReX is to establish a cutting-edge European infrastructure offering Trans-national Access (TA) of PDX resources to academic and industrial cancer researchers, including the distribution of cryopreserved samples to third parties, the structured biobanking of user-developed models, and the performance of efficacy studies. To ensure interoperability in services, TA initiatives will be backed by Networking Activities (NAs); these will be mainly centred around the establishment of standard procedures for PDX quality control, long-term storage and therapeutic mouse trials. NAs will also entail the adoption of shared ethics parameters for animal experimentation, the wide dissemination of services and project results, and the design of plans to ensure sustainability of the infrastructure. User outreach will be maximised by Joint Research Activities through a three-pronged approach: i) the implementation of a public Data Portal for efficient and user-friendly query and visualisation of clinical, molecular and pharmacological annotation of the models; ii) a cross-validation mouse trial to harmonise inter-laboratory procedures, thus improving the quality and reliability of service provision; and iii) the development of exploratory, more advanced PDX-based preclinical platforms, such as orthotopic and humanised models and in vitro PDX-derived cells. Capitalising on all these assets, EDIReX will contribute to structuring the European Research Area and global cooperation of research infrastructures.
Dziedzina nauki
Słowa kluczowe
Program(-y)
Zaproszenie do składania wniosków
Zobacz inne projekty w ramach tego zaproszeniaSzczegółowe działanie
H2020-INFRAIA-2017-1-two-stage
System finansowania
RIA - Research and Innovation actionKoordynator
10124 Torino
Włochy
Zobacz na mapie
Uczestnicy (18)
3000 Leuven
Zobacz na mapie
CB2 1TN Cambridge
Zobacz na mapie
75231 Paris
Zobacz na mapie
08035 Barcelona
Zobacz na mapie
1066 CX Amsterdam
Zobacz na mapie
601 77 Brno
Zobacz na mapie
69117 Heidelberg
Zobacz na mapie
8010 Graz
Zobacz na mapie
2 Dublin
Zobacz na mapie
08908 L'HOSPITALET DEL LLOBREGAT
Zobacz na mapie
M13 9PL Manchester
Zobacz na mapie
9713 GZ Groningen
Zobacz na mapie
0450 Oslo
Zobacz na mapie
20121 Milano
Zobacz na mapie
28942 Fuenlabrada
Zobacz na mapie
10134 Torino
Zobacz na mapie
Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.
3512 KC Utrecht
Zobacz na mapie
75020 Paris
Zobacz na mapie
Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.